Skip to main content

Military Health System

Important Notice about Pharmacy Operations

Change Healthcare Cyberattack Impact on MHS Pharmacy Operations. Read the statement to learn more. 

Skip subpage navigation

IHD COVID-19 Vaccine Resource Center for Health Care Personnel

COVID-19 Vaccine Training Materials available from the CDC

Find below information and resources on the COVID-19 Vaccination Program from the Defense Health Agency Immunization Healthcare Division. This information is geared toward health care personnel in the Department of Defense. This page is reviewed daily and more content is added as soon as it becomes available.

Note: The Food and Drug Administration has authorized the use of an updated 2023-24 COVID-19 vaccine formulation. The bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines and the original Novavax formulation are no longer authorized for use in the United States.

Ordering guidance for DOD activities:

The following documents have been added to provide updated guidance on ordering the 2023-24 COVID-19 vaccine formulations:

Policies Date
Coronavirus Disease 2019 Vaccine Guidance (Deputy Secretary of Defense) Dec. 7, 2020
Novavax Information Date
Information Paper on Novavax COVID-19 Vaccine July 25, 2022
Novavax COVID-19 Vaccine: Information on Fetal Cell/Fetal Tissue July 22, 2022
Forms Date
DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 26. Previous versions are obsolete. (Right-click and save this document to your desktop in order to fill it out and add digital signature)
October 2023
DHA Form 236, Pediatric (6 months-11 years) COVID-19 Vaccine Screening and Immunization Documentation, Version 13. Previous versions are obsolete. (Right-click and save this document to your desktop in order to fill it out and add digital signature)
October 2023
DHA Form 177, Potentially Compromised Temperature Sensitive Medical Product Worksheet
September 2023
DD Form 2875, System Authorization Access Request (SAAR) (right-click on link and choose "Save link as..." Then open the pdf from your computer)
May 2022
DD Form 2992, Medical Recommendation for Flying or Special Operations Duty (right-click on link and choose "Save link as..." Then open the pdf from your computer)
January 2015
U.S. Food and Drug Administration (FDA) Vaccine Adverse Events Reporting System (VAERS) Form 2.0
November 2023
Translated Pre-Vaccination Checklists
Prevaccination Checklist for COVID-19 Vaccines (Dari) (Sept. 3, 2021)
Sept. 3, 2021
Prevaccination Checklist for COVID-19 Vaccines (Pashto) (Sept. 3, 2021)
Sept. 3, 2021
Prevaccination Checklist for COVID-19 Vaccines (English Key) (Sept. 3, 2021)
Sept. 3, 2021
Standing Orders Date
Standing Orders for Administering COVID-19 Vaccine (Pediatric) (Right-click and save this document to your desktop in order to fill it out and add digital signature)
Oct. 20, 2023
Standing Orders for Administering COVID-19 Vaccine (Adult) (Right-click and save this document to your desktop in order to fill it out and add digital signature)
Oct. 20, 2023
Vaccine Information Statement Date
COVID-19 Vaccine: What You Need to Know Oct. 19, 2023
Competency Assessment Checklists Date
Competency Assessment Checklist: Uniformed Support of COVID-19 Vaccinations (Right-click and save this document to your desktop in order to fill it out and add digital signature)
November 2021
Pfizer (12 and older) minus-90 Vaccine Storage and Handling Competency Assessment (Right-click and save this document to your desktop in order to fill it out and add digital signature)
November 2021
Pfizer (ages 5-11) minus-90 Vaccine Storage and Handling Competency Assessment (Right-click and save this document to your desktop in order to fill it out and add digital signature)
November 2021
Manufacturer Package Inserts Date
COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine (This vaccine is licensed for use in people 12 and older)
Oct. 17, 2023
SPIKEVAX (Moderna) COVID-19 Vaccine (This vaccine is licensed for use in people 12 and older)
Sept. 11, 2023
Emergency Use Authorization Fact Sheets Date
Novavax
Fact Sheet for Recipients and Caregivers about Novavax COVID-19 Vaccine Oct. 3, 2023
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Novavax COVID-19 Vaccine
Oct. 3, 2023
Pifzer-BioNTech
Fact Sheet for Recipients and Caregivers about Pfizer-BioNTech COVID-19 Vaccine (2023-2024 formulation) Sept. 11, 2023
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Pfizer-BioNTech COVID-19 Vaccine (2023-2024 formulation) Dec. 8, 2023
Moderna
Fact Sheet for Recipients and Caregivers about Moderna COVID-19 Vaccine (2023-2024 formulation) 
Sept. 11, 2023
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Moderna COVID-19 Vaccine (2023-2024 formulation)
Nov. 1, 2023
Clinical Considerations Date
Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States Feb. 12, 2024
Clinical Guidelines for COVID-19 Vaccination Medical Exemption Considerations
Oct. 14, 2021
Vaccine Product Information Date
Bullet Background Paper on Pfizer-BioNTech COVID-19 Vaccine Buffer Solution Nov. 8, 2021
U.S. COVID-19 Vaccine Product Information
Nov. 6, 2023
Medical Logistics Date
DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program May 10, 2021
Vaccine Storage and Handling Resources Date
Pfizer-BioNTech
Vaccine Summary At A Glance Jan. 24, 2024
Vaccine Storage and Beyond-Use Date Tracking Labels
Jan. 22, 2024
Transporting Vaccine for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations
May 2, 2023
Temperature Log for Ultra-Cold Vaccine Storage (Fahrenheit)
Aug. 24, 2021
Temperature Log for Ultra-Cold Vaccine Storage (Celsius)
Aug. 24, 2021
Vaccine Expiration Date Tracking Tool
Jan. 7, 2021
Moderna
Vaccine Summary At A Glance Oct. 5, 2023
Vaccine Vial Puncture Tracker
November 2021
Vaccine Storage and Beyond-Use Date Tracking Labels
Oct. 17, 2023
Transporting Vaccine for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations
May 2, 2023
Temperature Log for Frozen Vaccine Storage (Celsius)
July 15, 2021
Temperature Log for Frozen Vaccine Storage (Fahrenheit)
July 15, 2021
Temperature Log for Refrigerator Vaccine Storage (Celsius)
Jan. 7, 2021
Temperature Log for Refrigerator Vaccine Storage (Fahrenheit)
Jan. 7, 2021
Vaccine Expiration Date Tracking Tool
Jan. 7, 2021
Novavax
Vaccine Summary At A Glance Dec. 1, 2023
Vaccine Storage and Beyond-Use Date Tracking Labels
Dec. 1, 2023
Temperature Log when Transporting Vaccine at Refrigerated Temperatures
Feb. 18, 2021
Temperature Log for Refrigerator Vaccine Storage (Celsius)
Jan. 7, 2021
Temperature Log for Refrigerator Vaccine Storage (Fahrenheit)
Jan. 7, 2021
Vaccine Storage Troubleshooting Record for Temperature Excursions
August 2021
Vaccine Expiration Date Tracking Tool
Jan. 7, 2021
Adverse Events Date
Information paper on Options for COVID-19 Vaccination Following Myopericarditis Oct. 20, 2021
DOD Clinical Guidelines for Post-Vaccination Associated Myopericarditis, Version 13
February 2024
Adverse Events for Healthcare Providers webpage
Nov. 8, 2023
Vaccine Safety Date
v-safe After Vaccination Health Checker Information Sheet (CDC) June 10, 2022
Safety Data Sheet: Pfizer-BioNTech COVID-19 Vaccine
Nov. 16, 2020
Safety Data Sheet: Dry ice
Nov. 20, 2020
Dry Ice Safety for Healthcare Professionals
Jan. 7, 2021
Advisory Committee on Immunization Practices Recommendations Date
Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020 Dec. 3, 2020
Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
Dec. 22, 2020
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
July 6, 2021
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
Aug. 13, 2021
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
Aug. 27, 2021
The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
Nov. 5, 2021
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
July 1, 2022
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
Nov. 11, 2022
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
June 16, 2023
Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
Oct. 20, 2023
Pfizer-BioNTech
The Advisory Committee on Immunization Practices Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020
Dec. 13, 2020
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020
Jan. 15, 2021
Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
May 14, 2021
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
Sept. 24, 2021
Pfizer-BioNTech (Pediatric)
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
Nov. 5, 2021
Moderna
The Advisory Committee on Immunization Practices Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020
Dec. 20, 2020
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021
Jan. 29, 2021
Novavax
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
Aug. 5, 2022
Resources for Building Vaccine Confidence
Building Vaccine Confidence in Health Systems and Clinics
June 2021
Patient Education Resources Date
Answering Your Questions About the New COVID-19 Vaccines
Dec. 11, 2020
Mass Immunizations Date
Recommendations for Mass Immunization Events During Pandemic Conditions
Dec. 28, 2020

You also may be interested in...

Last Updated: February 13, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery